open access

Vol 11, No 6 (2016)
Review Papers
Published online: 2017-01-16
Get Citation

The meaning of neutrophil-lymphocyte ratio in patients with cardiovascular diseases

Justyna Kuźniar-Placek, Magdalena Pacyna, Andrzej Jaroszyński
DOI: 10.5603/FC.2016.0109
·
Folia Cardiologica 2016;11(6):525-528.

open access

Vol 11, No 6 (2016)
Review Papers
Published online: 2017-01-16

Abstract

Cardiovascular diseases (CVD) are still the most often cause of mortality in the population. The important role in the development of cardiovascular diseases is a low-grade inflammation. One of the indicators of this state is neutrophil- -lymphocyte ratio (NLR). Neutrophil-lymphocyte ratio is defined as the quotient of the number of neutrophils and lymphocytes. Still unknown is the normal value of NLR. Normal and pathological values depend on the kind of disease. The meaning of NLR has been proven in some cardiovascular diseases such as ischemic heart disease, arrhythmias or hypertension. In these diseases, NLR is an important predictor of worse prognosis, shorter time of survive or life- -threatening arrhythmias. The prevalence of CVD, even in young population, is the main cause of the search for new, low-cost and available methods for diagnosing cardiovascular diseases.

Abstract

Cardiovascular diseases (CVD) are still the most often cause of mortality in the population. The important role in the development of cardiovascular diseases is a low-grade inflammation. One of the indicators of this state is neutrophil- -lymphocyte ratio (NLR). Neutrophil-lymphocyte ratio is defined as the quotient of the number of neutrophils and lymphocytes. Still unknown is the normal value of NLR. Normal and pathological values depend on the kind of disease. The meaning of NLR has been proven in some cardiovascular diseases such as ischemic heart disease, arrhythmias or hypertension. In these diseases, NLR is an important predictor of worse prognosis, shorter time of survive or life- -threatening arrhythmias. The prevalence of CVD, even in young population, is the main cause of the search for new, low-cost and available methods for diagnosing cardiovascular diseases.

Get Citation

Keywords

neutrophil-lymphocyte ratio; cardiovascular diseases; inflammation

About this article
Title

The meaning of neutrophil-lymphocyte ratio in patients with cardiovascular diseases

Journal

Folia Cardiologica

Issue

Vol 11, No 6 (2016)

Pages

525-528

Published online

2017-01-16

DOI

10.5603/FC.2016.0109

Bibliographic record

Folia Cardiologica 2016;11(6):525-528.

Keywords

neutrophil-lymphocyte ratio
cardiovascular diseases
inflammation

Authors

Justyna Kuźniar-Placek
Magdalena Pacyna
Andrzej Jaroszyński

References (19)
  1. http://ec.europa.eu/eurostat/statistics-explained//index.php/Causes_of_death_statistic/pl (04.04.2016).
  2. Zdrojewski T, Ignaszewska-Wyrzykowska A, Wierucki Ł, et al. Modelowy projekt prewencji chorób układu krążenia na przykładzie doświadczeń Programu SOPKARD. Choroby Serca i Naczyń. 2004; 1: 115–129.
  3. Głuszek J. Niedokrwienie serca i nadciśnienie tętnicze u chorych na przewlekłą obturacyjną chorobę płuc i obturacyjny bezdech senny. Pneumonol Alergol Pol. 2013; 81: 567–574.
  4. Nowicka G. Praktyczne możliwości wykorzystania markerów stanu zapalnego w ocenie ryzyka choroby niedokrwiennej serca. Przew Lek. 2005; 2: 52–55.
  5. Białas M, Gryszkiewicz M. Podejrzenie ostrego zapalenia wyrostka robaczkowego — trudności w rozpoznaniu i metody wspomagające diagnostykę. Now Lek. 2006; 75: 184–192.
  6. Soylu K, Gedikli Ö, Dagasan G, et al. Neutrophil-to-lymphocyte ratio predicts coronary artery lesion complexity and mortality after non-ST-segment elevation acute coronary syndrome. Rev Port Cardiol. 2015; 34(7-8): 465–471.
  7. Afari ME, Bhat T. Neutrophil to lymphocyte ratio (NLR) and cardiovascular diseases: an update. Expert Rev Cardiovasc Ther. 2016; 14(5): 573–577.
  8. Liu X, Zhang Q, Wu H, et al. Blood Neutrophil to Lymphocyte Ratio as a Predictor of Hypertension. Am J Hypertens. 2015; 28(11): 1339–1346.
  9. Ha KS, Lee J, Jang GiY, et al. Value of neutrophil-lymphocyte ratio in predicting outcomes in Kawasaki disease. Am J Cardiol. 2015; 116(2): 301–306.
  10. Ozturk C, Balta S, Balta I, et al. Neutrophil-lymphocyte ratio and carotid-intima media thickness in patients with Behçet disease without cardiovascular involvement. Angiology. 2015; 66(3): 291–296.
  11. Yalcin M, Aparci M, Uz O, et al. Neutrophil-lymphocyte ratio may predict left atrial thrombus in patients with nonvalvular atrial fibrillation. Clin Appl Thromb Hemost. 2015; 21(2): 166–171.
  12. Gibson PH, Cuthbertson BH, Croal BL, et al. Usefulness of neutrophil/lymphocyte ratio as predictor of new-onset atrial fibrillation after coronary artery bypass grafting. Am J Cardiol. 2010; 105(2): 186–191.
  13. Yilmaz M, Tenekecioglu E, Arslan B, et al. White Blood Cell Subtypes and Neutrophil-Lymphocyte Ratio in Prediction of Coronary Thrombus Formation in Non-ST-Segment Elevated Acute Coronary Syndrome. Clin Appl Thromb Hemost. 2015; 21(5): 446–452.
  14. Benites-Zapata VA, Hernandez AV, Nagarajan V, et al. Usefulness of neutrophil-to-lymphocyte ratio in risk stratification of patients with advanced heart failure. Am J Cardiol. 2015; 115(1): 57–61.
  15. Ipek G, Onuk T, Karatas MB, et al. Relationship between Neutrophil-to-Lymphocyte Ratio and Left Ventricular Free Wall Rupture in Acute Myocardial Infarction. Cardiology. 2015 [Epub ahead of print]; 132(2): 105–110.
  16. Çiçek G, Açıkgoz SK, Bozbay M, et al. Neutrophil-lymphocyte ratio and platelet-lymphocyte ratio combination can predict prognosis in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Angiology. 2015; 66(5): 441–447.
  17. Tan TP, Arekapudi A, Metha J, et al. Neutrophil-lymphocyte ratio as predictor of mortality and morbidity in cardiovascular surgery: a systematic review. ANZ J Surg. 2015; 85(6): 414–419.
  18. Pan W, Zhao D, Zhang C, et al. Application of neutrophil/lymphocyte ratio in predicting coronary blood flow and mortality in patients with ST-elevation myocardial infarction undergoing percutaneous coronary intervention. J Cardiol. 2015; 66(1): 9–14.
  19. Nalbant A, Cinemre H, Kaya T, et al. Neutrophil to lymphocyte ratio might help prediction of acute myocardial infarction in patients with elevated serum creatinine. Pak J Med Sci. 2016; 32(1): 106–110.

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

 

Wydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl